Dr. Robert Liwski is the Head of the Division on Hematological Pathology, Medical Director of the HLA Laboratory and Professor of Pathology at the Queen Elizabeth II Health Sciences Centre and Dalhousie University in Halifax, Canada. He is also the Medical and Scientific Director of the HLA Laboratory at the Canadian Blood Services Head Office in Ottawa. His research interests include transplantation immunology and optimization of diagnostic testing in transplantation. Dr. Liwski obtained his PhD in Transplantation Immunology in 1999 (Dalhousie), his MD degree in 2003 (Dalhousie) and completed his fellowship training in Hematological Pathology in 2006 (Dalhousie). He also completed the ASHI Director Training Fellowship in 2012. Dr. Liwski has been an active member of the histocompatibility community, contributing articles to Human Immunology, ASHI Quarterly and teaching topics in histocompatibility at several venues including ASHI Annual Meetings and Regional Workshops, the Georgetown University Lecture Series, and the American Foundation for Donation and Transplantation (AFDT) Histocompatibility Specialist Course. Within ASHI, Dr. Liwski has been a member of the Proficiency Testing Committee (since 2014), Proficiency Testing Executive Committee (since 2016; Program Director 2020), the Director Training Review and Credentialing (DTRC) Committee (2016-2020), ASHI Quarterly Editorial Board (since 2017; Editor-in-chief since 2021) and the ASHI Board of Directors (2016-2019).